Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

Concurrent Gastric and Pulmonary Mucosa-Associated Lymphoid Tissue Lymphomas with Pre-Existing Intrinsic Chronic Inflammation: A Case Report and a Review of the Literature

Oh S, Kim N, Oh DH, Bang SM, Choi YJ, Lee JY, Lee KW, Yoon HI, Yang HC, Paik JH, Lee DH, Jung HC

  • Gut Liver.
  • 2015 May;9(3):424-429.
  • doi: 10.5009/gnl14072
Herein, we report a rare case of concurrent gastric and pulmonary mucosa-associated lymphoid tissue (MALT) lymphomas. A 65-year-old man who had been diagnosed with Helicobacter pylori-positive gastric MALT lymphoma received...
Endoscopic Management of Bile Leakage after Liver Transplantation

Oh D, Lee SK, Song TJ, Park DH, Lee SS, Seo DW, Kim MH

  • Gut Liver.
  • 2015 May;9(3):417-423.
  • doi: 10.5009/gnl14117
BACKGROUND/AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) can be an effective treatment for bile leakage after liver transplantation. We evaluated the efficacy of endoscopic treatment in liver transplantation in patients who developed...
Pyrrolidine Dithiocarbamate Inhibits Nuclear Factor kappaB and Toll-Like Receptor 4 Expression in Rats with Acute Necrotizing Pancreatitis

Xu M, Wang KN, Wu K, Wang XP

  • Gut Liver.
  • 2015 May;9(3):411-416.
  • doi: 10.5009/gnl14050
BACKGROUND/AIMS: To investigate the expression of Toll-like receptor 4 (TLR4) in the pancreases of rats with acute necrotizing pancreatitis (ANP) and any changes upon treatment with pyrrolidine dithiocarbamate (PDTC), an...
Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees

Kim JK, Lee KS, Choi JR, Chung HJ, Jung DH, Lee KA, Lee JI

  • Gut Liver.
  • 2015 May;9(3):405-410.
  • doi: 10.5009/gnl14202
BACKGROUND/AIMS: The controlled attenuation parameter (CAP) implemented in FibroScan(R) is reported to be a non-invasive means of detecting steatosis (>10% steatosis). We aimed to evaluate the usefulness of CAP in...
Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy

Moon JC, Kim SH, Kim IH, Lee CH, Kim SW, Lee SO, Lee ST, Kim DG

  • Gut Liver.
  • 2015 May;9(3):395-404.
  • doi: 10.5009/gnl14170
BACKGROUND/AIMS: We investigated factors associated with the disease progression and development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients during long-term oral nucleos(t)ide analog (NA) therapy. METHODS: This retrospective...
Sonographic Evaluation of Gallbladder Motility in Children with Chronic Functional Constipation

Mehra R, Sodhi KS, Saxena A, Thapa BR, Khandelwal N

  • Gut Liver.
  • 2015 May;9(3):388-394.
  • doi: 10.5009/gnl13414
BACKGROUND/AIMS: Studies in adults suggest that constipation may not be a purely colonic pathology and may be a component of a generalized gastrointestinal (GI) motor disorder in which proximal GI...
Cytokine Expression of Microscopic Colitis Including Interleukin-17

Park E, Park YS, Park DR, Jung SA, Han DS, Jang BI, Kim YH, Kim WH, Jo YJ, Lee KH, Lee WM, Kim EK, Koo HS

  • Gut Liver.
  • 2015 May;9(3):381-387.
  • doi: 10.5009/gnl13439
BACKGROUND/AIMS: Microscopic colitis is characterized by chronic watery diarrhea with specific pathological changes that can be diagnosed by microscopic examination. We performed immunohistochemical analysis of proinflammatory cytokines to investigate the...
Expression of TIM-3, Human beta-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy

Kim MJ, Lee WY, Choe YH

  • Gut Liver.
  • 2015 May;9(3):370-380.
  • doi: 10.5009/gnl13408
BACKGROUND/AIMS: This study investigated the expression of T cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3), human beta-defensin (HBD)-2, forkhead box protein 3 (FOXP3), and the frequency of CD4+ CD25+ FOXP3+...
Nucleotide Binding Oligomerization Domain 1 Is an Essential Signal Transducer in Human Epithelial Cells Infected with Helicobacter pylori That Induces the Transepithelial Migration of Neutrophils

Kim BJ, Kim JY, Hwang ES, Kim JG

  • Gut Liver.
  • 2015 May;9(3):358-369.
  • doi: 10.5009/gnl13218
BACKGROUND/AIMS: The cytosolic host protein nucleotide binding oligomerization domain 1 (Nod1) has emerged as a key pathogen recognition molecule for innate immune responses in epithelial cells. The purpose of the...
Prior Radial-Scanning Endoscopic Ultrasonography Training Did Not Contribute to Subsequent Linear-Array Endoscopic Ultrasonography Study Performance in the Stomach of a Porcine Model

Xu W, Liu Y, Pan P, Guo Y, Wu RP, Yao YZ

  • Gut Liver.
  • 2015 May;9(3):353-357.
  • doi: 10.5009/gnl13419
BACKGROUND/AIMS: The optimal training mode for linear array endoscopic ultrasonography (EUS) has not been established. Prior radial-scanning EUS training seems to improve subsequent linear array EUS learning. The objective of...
Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients

Chang SS, Hu HY

  • Gut Liver.
  • 2015 May;9(3):346-352.
  • doi: 10.5009/gnl13451
BACKGROUND/AIMS: The connection between Helicobacter pylori and complicated peptic ulcer disease in peptic ulcer bleeding (PUB) patients taking nonsteroidal anti-inflammatory drugs has not been established. In this study, we sought...
Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection

Bang CS, Kim YS, Park SH, Kim JB, Baik GH, Suk KT, Yoon JH, Kim DJ

  • Gut Liver.
  • 2015 May;9(3):340-345.
  • doi: 10.5009/gnl13399
BACKGROUND/AIMS: Helicobacter pylori colonizes on the apical surface of gastric surface mucosal cells and the surface mucous gel layer. Pronase is a premedication enzyme for endoscopy that can disrupt the...
Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy

Camilleri

  • Gut Liver.
  • 2015 May;9(3):332-339.
  • doi: 10.5009/gnl14397
Bile acid diarrhea (BAD) is usually seen in patients with ileal Crohn's disease or ileal resection. However, 25% to 50% of patients with functional diarrhea or diarrhea-predominant irritable bowel syndrome...
Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome

Bennet SM, Ohman L, Simren M

  • Gut Liver.
  • 2015 May;9(3):318-331.
  • doi: 10.5009/gnl14344
Irritable bowel syndrome (IBS) is a multifactorial functional disorder with no clearly defined etiology or pathophysiology. Modern culture-independent techniques have improved the understanding of the gut microbiota's composition and demonstrated...
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma

Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC)

  • Gut Liver.
  • 2015 May;9(3):267-317.
  • doi: 10.5009/gnl14460
The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center,...
Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions

Shim JJ

  • Gut Liver.
  • 2015 May;9(3):265-266.
  • doi: 10.5009/gnl15105
No abstract available.
Cross-Regulation of Innate and Adaptive Immunity: A New Perspective for the Pathogenesis of Inflammatory Bowel Disease

Oh DY, Koh SJ

  • Gut Liver.
  • 2015 May;9(3):263-264.
  • doi: 10.5009/gnl15123
No abstract available.
Practical Suggestions to Train Better-Performing Endosonographers

Kim EY

  • Gut Liver.
  • 2015 May;9(3):261-262.
  • doi: 10.5009/gnl15124
No abstract available.
There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding

Lee SY

  • Gut Liver.
  • 2015 May;9(3):259-260.
  • doi: 10.5009/gnl14499
No abstract available.
Mucolytics as Adjuvant Agent to Improve Helicobacter pylori Eradication Rate: Still Long and Winding Road to Positive Results

Yoon H, Lee DH

  • Gut Liver.
  • 2015 May;9(3):257-258.
  • doi: 10.5009/gnl15117
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr